Skip to main content
. 2015 Oct 8;55:249–255. doi: 10.1007/s40262-015-0315-x

Fig. 1.

Fig. 1

Individual changes in trough concentration (C trough) values for a tamoxifen and b endoxifen following the switch from a potent cytochrome P450 (CYP) 2D6-inhibiting antidepressant (paroxetine [Parox] or fluoxetine [Fluox]) to a weak CYP2D6-inhibiting antidepressant (escitalopram), and mean plasma concentration–time profiles for c tamoxifen and d endoxifen during concomitant use of paroxetine or fluoxetine (white circles) and during concomitant use of escitalopram (black circles)